Analysis of TPE Treatments With multiFiltratePRO

Recruiting now

Conditions studied: Autoimmune Diseases

In brief

Analysis of therapeutic plasma exchange (TPE) treatments to assess the performance of the TPE mode of multiFiltratePRO based on the successful exchange of plasma from whole blood. The multiFiltratePRO is a device for extracorporeal blood purification treatments.

Key facts

Study ID

NCT06272084

Run by

Fresenius Medical Care Deutschland GmbH

People needed

60

Starts

2024-05-22

Expected to finish

2025-12-01

Last updated by the study team

2025-08-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Body weight ≥40kg irrespective of the age
• Patients with indication for TPE treatment according to ASFA guideline
• Patients have been treated with TPE between January 2019 and October 2023
• Availability of at least 50% of the parameters to be documented for the patient

You may not qualify if…

• Participation in an interventional clinical study during the retrospectively collected TPE treatment data
• Previous documentation within this study
• Simultaneous use of another filter for additional therapy form

Where it is running

• Klinikum Aschaffenburg-Alzenau — Aschaffenburg, Bavaria, Germany (enrolling)
• Universitätsklinikum Würzburg — Würzburg, Bavaria, Germany (enrolling)
• Charité-Universitätsmedizin Berlin — Berlin, State of Berlin, Germany (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.